240 related articles for article (PubMed ID: 36038419)
1. Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC.
Chen P; Yang W; Hong T; Miyazaki T; Dirisala A; Kataoka K; Cabral H
Biomaterials; 2022 Sep; 288():121748. PubMed ID: 36038419
[TBL] [Abstract][Full Text] [Related]
2. Selective Intracellular Delivery of Antibodies in Cancer Cells with Nanocarriers Sensing Endo/Lysosomal Enzymatic Activity.
Chen P; Yang W; Mochida Y; Li S; Hong T; Kinoh H; Kataoka K; Cabral H
Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202317817. PubMed ID: 38342757
[TBL] [Abstract][Full Text] [Related]
3. The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery.
Smith SA; Selby LI; Johnston APR; Such GK
Bioconjug Chem; 2019 Feb; 30(2):263-272. PubMed ID: 30452233
[TBL] [Abstract][Full Text] [Related]
4. Preoccupation of Empty Carriers Decreases Endo-/Lysosome Escape and Reduces the Protein Delivery Efficiency of Mesoporous Silica Nanoparticles.
Li WQ; Sun LP; Xia Y; Hao S; Cheng G; Wang Z; Wan Y; Zhu C; He H; Zheng SY
ACS Appl Mater Interfaces; 2018 Feb; 10(6):5340-5347. PubMed ID: 29345456
[TBL] [Abstract][Full Text] [Related]
5. Endosomal Escape of Bioactives Deployed via Nanocarriers: Insights Into the Design of Polymeric Micelles.
Butt AM; Abdullah N; Rani NNIM; Ahmad N; Amin MCIM
Pharm Res; 2022 Jun; 39(6):1047-1064. PubMed ID: 35619043
[TBL] [Abstract][Full Text] [Related]
6. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery.
Panyam J; Zhou WZ; Prabha S; Sahoo SK; Labhasetwar V
FASEB J; 2002 Aug; 16(10):1217-26. PubMed ID: 12153989
[TBL] [Abstract][Full Text] [Related]
7. Endosomal escape for cell-targeted proteins. Going out after going in.
Voltà-Durán E; Parladé E; Serna N; Villaverde A; Vazquez E; Unzueta U
Biotechnol Adv; 2023; 63():108103. PubMed ID: 36702197
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal monitoring endocytic and cytosolic pH gradients with endosomal escaping pH-responsive micellar nanocarriers.
Hu J; Liu G; Wang C; Liu T; Zhang G; Liu S
Biomacromolecules; 2014 Nov; 15(11):4293-301. PubMed ID: 25317967
[TBL] [Abstract][Full Text] [Related]
9. Controlling endosomal escape using nanoparticle composition: current progress and future perspectives.
Cupic KI; Rennick JJ; Johnston AP; Such GK
Nanomedicine (Lond); 2019 Jan; 14(2):215-223. PubMed ID: 30511881
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of intracellular trafficking, cytosolic bioavailability, and target manipulation of an antibody delivery platform.
Lv W; Champion JA
Nanomedicine; 2021 Feb; 32():102315. PubMed ID: 33065253
[TBL] [Abstract][Full Text] [Related]
11. Metal-Organic Framework-Based Nanoplatform for Intracellular Environment-Responsive Endo/Lysosomal Escape and Enhanced Cancer Therapy.
Dong K; Wang Z; Zhang Y; Ren J; Qu X
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31998-32005. PubMed ID: 30178654
[TBL] [Abstract][Full Text] [Related]
12. Protein Delivery into the Cell Cytosol using Non-Viral Nanocarriers.
Lee YW; Luther DC; Kretzmann JA; Burden A; Jeon T; Zhai S; Rotello VM
Theranostics; 2019; 9(11):3280-3292. PubMed ID: 31244954
[TBL] [Abstract][Full Text] [Related]
13. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption.
Lee CS; Park W; Park SJ; Na K
Biomaterials; 2013 Dec; 34(36):9227-36. PubMed ID: 24008035
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in tumor pH targeting nanotechnology.
Lee ES; Gao Z; Bae YH
J Control Release; 2008 Dec; 132(3):164-70. PubMed ID: 18571265
[TBL] [Abstract][Full Text] [Related]
15. A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.
Wang J; Bhattacharyya J; Mastria E; Chilkoti A
J Control Release; 2017 Aug; 260():100-110. PubMed ID: 28576641
[TBL] [Abstract][Full Text] [Related]
16. Escape sites from the endo-lysosomal trafficking route manipulate exocytosis of nanoparticles in polar epithelium.
Wang L; Li Y; Liu X; Xing L; Wu R; Huang Y
Biomater Sci; 2024 May; 12(10):2660-2671. PubMed ID: 38592706
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers Made of Proteins: Intracellular Visualization of a Smart Biodegradable Drug Delivery System.
Frey ML; Han S; Halim H; Kaltbeitzel A; Riedinger A; Landfester K; Lieberwirth I
Small; 2022 Apr; 18(15):e2106094. PubMed ID: 35224835
[TBL] [Abstract][Full Text] [Related]
18. Endosomal Escape and Cytosolic Penetration of Macromolecules Mediated by Synthetic Delivery Agents.
Brock DJ; Kondow-McConaghy HM; Hager EC; Pellois JP
Bioconjug Chem; 2019 Feb; 30(2):293-304. PubMed ID: 30462487
[TBL] [Abstract][Full Text] [Related]
19. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.
Wu W; Luo L; Wang Y; Wu Q; Dai HB; Li JS; Durkan C; Wang N; Wang GX
Theranostics; 2018; 8(11):3038-3058. PubMed ID: 29896301
[TBL] [Abstract][Full Text] [Related]
20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
